Repeated exposure to blue light does not improve psoriasis - 29/08/11
Abstract |
Background: Increased endogenous levels of protoporphyrin IX (PpIX) have been reported in the skin of patients with psoriasis. Activation of PpIX with blue light after exogenous topical application of its precursor, aminolevulinic acid, can improve psoriasis. Light activation of endogenous PpIX for the treatment of psoriasis has never been studied. Objective: The purpose of this study was to determine the efficacy of multiple exposures to blue light in patients with plaque psoriasis. Methods: A total of 17 patients with plaque psoriasis presenting increased endogenous level of PpIX were enrolled. Of the 2 identified plaques on each patient, 1 was exposed to 10 J/cm2 of blue light from a fluorescent panel 3 times per week for 4 consecutive weeks. Plaque severity was assessed in a blinded fashion. PpIX levels were measured with in vivo fluorescence spectroscopy weekly. Results: A single exposure to blue light induced almost complete photobleaching of PpIX. There was no significant difference between the mean psoriasis severity score of the plaques before and after 12 exposures to blue light. Conclusion: Repeated exposure to blue light did not improve psoriasis. (J Am Acad Dermatol 2003;49:55-8.)
Le texte complet de cet article est disponible en PDF.Plan
Funding sources: None. |
|
Conflict of interest: None identified. |
|
Reprint requests: Robert Bissonnette, MD, MSc, FRCPC, Division of Dermatology, University of Montreal Hospital Centre, Notre-Dame Hospital, 1560 Sherbrooke St East, Room K-5201, Montreal, Quebec, Canada H2L 4M1. E-mail: rbissonn@globetrotter.net. |
|
0190-9622/2003/$30.00 + 0 |
Vol 49 - N° 1
P. 55-58 - juillet 2003 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?